SANG (SANG) Stock Price & Analysis
SANG (SANG) rose 1.22% to USD 4.16 as of July 25, 2026 at 06:12 UTC, according to Nexqual real-time market data.
SANG last closed at USD 4.11; the session ranged USD 4.1–4.16 on volume of 8,353 shares. Market capitalization is $138.44M, with a 52-week range of USD 3.4–6.46 (NMS). Source: Nexqual, July 25, 2026 at 06:12 UTC.
Key Statistics (as of July 25, 2026 at 06:12 UTC)
| Price | USD 4.16 |
|---|---|
| Change | ▲ 1.22% (up) |
| Previous Close | USD 4.11 |
| Open | USD 4.11 |
| Day Range | USD 4.1 – 4.16 |
| 52-Week Range | USD 3.4 – 6.46 |
| Volume | 8,353 shares |
| Market Cap | $138.44M |
| Exchange | NMS |
Technical Analysis (SANG)
Nexqual's technical model rates SANG "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 06:12 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 66.28 (neutral) |
| vs SMA50 | Above (USD 3.8) |
| MACD | 0.1 (positive) |
Analyst Ratings (SANG)
Wall Street analysts rate SANG "None" based on 1 analysts, with a mean price target of USD 4 (range USD 4–4), per Nexqual as of July 25, 2026 at 06:12 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 4 |
| High Target | USD 4 |
| Low Target | USD 4 |
| Buy / Hold / Sell | 5 / 1 / 0 |
Earnings (SANG)
| Next Earnings Date | 2026-09-16 |
|---|---|
| Revenue Estimate | $51.27M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -0.07 vs est -0.04 ▼ miss |
| 2025-12-31 | USD -0.06 vs est -0.06 ▲ beat |
| 2025-09-30 | USD -0.07 vs est -0.06 ▼ miss |
| 2025-06-30 | USD 0.01 vs est -0 ▲ beat |
Source: Nexqual, July 25, 2026 at 06:12 UTC.
Financials & Fundamentals (SANG)
| Total Revenue | $212.62M |
|---|---|
| Revenue Growth (YoY) | -12.20% |
| Gross Margin | +71.23% |
| Operating Margin | -4.15% |
| Profit Margin | -3.04% |
| ROE | -2.56% |
| Debt / Equity | 15.99 |
| Current Ratio | 0.9 |
| Total Cash | $15.29M |
| Total Debt | $39.72M |
| Free Cash Flow | $28.18M |
Source: Nexqual, July 25, 2026 at 06:12 UTC.
Financial Health Score (SANG)
Nexqual rates SANG's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 06:12 UTC.
| Growth | Weak — Revenue -4% YoY (annual), declining |
|---|---|
| Profitability | Solid — Gross margin 71%, operating -4% |
| Balance Sheet | Solid — $15M cash vs $40M debt |
| Cash Flow | Solid — FCF $28M, 12% margin |
| Efficiency | Critical — ROE -3%, ROA -0.8% |
Ownership (SANG)
| Insider Ownership | +26.67% |
|---|---|
| Institutional Ownership | +30.02% |
| Shares Outstanding | 33.28M |
| Float | 25.56M |
Source: Nexqual, July 25, 2026 at 06:12 UTC.
Leadership (SANG)
SANG is led by Charles J. Salameh (age 60), CEO & Director, per Nexqual as of July 25, 2026 at 06:12 UTC.
| CEO & Director | Charles J. Salameh (age 60) |
|---|---|
| Chief Operating & Technology Officer | Jeremy Wubs |
| Senior VP of Finance & Interim CFO | Adrian Back |
| Managing Director of VoIP Supply | Paula Griffo |
Major Backers & Investors (SANG)
Notable institutional backers of SANG include PenderFund Capital Management Limited, Alberta Investment Management Corp, Intact Investment Management, Inc., according to Nexqual as of July 25, 2026 at 06:12 UTC.
Active Investors
| Investor | Stake |
|---|---|
| PenderFund Capital Management Limited | 8.48% |
| Alberta Investment Management Corp | 2.3% |
| Intact Investment Management, Inc. | 2.09% |
| PPM America Inc/IL | 2.07% |
| Ewing Morris & Co. Investment Partners Ltd. | 2.01% |
| TD Waterhouse Canada Inc. | 1.37% |
| Connor Clark & Lunn Investment Management Ltd | 0.71% |
| Arrowstreet Capital, Limited Partnership | 0.52% |
Source: Nexqual, July 25, 2026 at 06:12 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CVAS | CREATIVE VISTAS INC | USD 0 | ▲ 0% |
| MAGN | Magnera Corporation | USD 13.71 | ▲ 0.81% |
| LIPO | Lipella Pharmaceuticals Inc. | USD 0.03 | ▲ 0% |
| IGEN | iGen Networks Corp. | USD 0 | ▲ 0% |
| CINT | CI&T Inc | USD 3.11 | ▼ 0.96% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 06:12 UTC. This page is informational and not investment advice.